Cargando…
Troponin and Anti-Troponin Autoantibody Levels in Patients with Ventricular Noncompaction
Ventricular hypertrabeculation/noncompaction is a morphologic and functional anomaly of myocardium characterized by prominent trabeculae accompanied by deep recessus. Dilated cardiomyopathy with left ventricular failure is observed in these patients, while the cause or pathophysiologic nature of thi...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3585198/ https://www.ncbi.nlm.nih.gov/pubmed/23469039 http://dx.doi.org/10.1371/journal.pone.0057648 |
_version_ | 1782261118099521536 |
---|---|
author | Erer, Hatice Betül Güvenç, Tolga Sinan Kemik, Ahu Sarbay Yılmaz, Hale Yaka Kul, Şeref Altay, Servet Sayar, Nurten Kaya, Yüksel Eren, Mehmet |
author_facet | Erer, Hatice Betül Güvenç, Tolga Sinan Kemik, Ahu Sarbay Yılmaz, Hale Yaka Kul, Şeref Altay, Servet Sayar, Nurten Kaya, Yüksel Eren, Mehmet |
author_sort | Erer, Hatice Betül |
collection | PubMed |
description | Ventricular hypertrabeculation/noncompaction is a morphologic and functional anomaly of myocardium characterized by prominent trabeculae accompanied by deep recessus. Dilated cardiomyopathy with left ventricular failure is observed in these patients, while the cause or pathophysiologic nature of this complication is not known. Anti-troponin antibodies are formed against circulating cardiac troponins after an acute coronary event or conditions associated with chronic myocyte necrosis, such as dilated cardiomyopathy. In present study, we aimed to investigate cardiac troponins and anti troponin autoantibodies in ventricular noncompaction/hypertrabeculation patients with/without reduced ejection fraction. A total of 50 patients with ventricular noncompaction and 23 healthy volunteers were included in this study. Noncompaction/hypertrabeculation was diagnosed with two-dimensional echocardiography using appropriate criteria. Depending on ejection fraction, patients were grouped into noncompaction with preserved EF (LVEF >50%, n = 24) and noncompaction with reduced EF (LVEF <35%, n = 26) groups. Troponin I, troponin T, anti-troponin I IgM and anti-troponin T IgM were measured with sandwich immunoassay method using a commercially available kit. Patients with noncompaction had significantly higher troponin I (28.98±9.21 ng/ml in NCNE group and 28.11±10.42 ng/ml in NCLE group), troponin T (22.17±6.97 pg/ml in NCNE group and 22.78±7.76 pg/ml in NCLE group) and antitroponin I IgM (1.92±0.43 µg/ml in NCNE group and 1.79±0.36 µg/ml in NCLE group) levels compared to control group, while antitroponin T IgM and IgG were only elevated in patients with noncompaction and reduced EF (15.81±6.52 µg/ml for IgM and 16.46±6.25 µg/ml for IgG). Elevated cardiac troponins and anti-troponin I autoantibodies were observed in patients with noncompaction preceding the decline in systolic function and could indicate ongoing myocardial damage in these patients. |
format | Online Article Text |
id | pubmed-3585198 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-35851982013-03-06 Troponin and Anti-Troponin Autoantibody Levels in Patients with Ventricular Noncompaction Erer, Hatice Betül Güvenç, Tolga Sinan Kemik, Ahu Sarbay Yılmaz, Hale Yaka Kul, Şeref Altay, Servet Sayar, Nurten Kaya, Yüksel Eren, Mehmet PLoS One Research Article Ventricular hypertrabeculation/noncompaction is a morphologic and functional anomaly of myocardium characterized by prominent trabeculae accompanied by deep recessus. Dilated cardiomyopathy with left ventricular failure is observed in these patients, while the cause or pathophysiologic nature of this complication is not known. Anti-troponin antibodies are formed against circulating cardiac troponins after an acute coronary event or conditions associated with chronic myocyte necrosis, such as dilated cardiomyopathy. In present study, we aimed to investigate cardiac troponins and anti troponin autoantibodies in ventricular noncompaction/hypertrabeculation patients with/without reduced ejection fraction. A total of 50 patients with ventricular noncompaction and 23 healthy volunteers were included in this study. Noncompaction/hypertrabeculation was diagnosed with two-dimensional echocardiography using appropriate criteria. Depending on ejection fraction, patients were grouped into noncompaction with preserved EF (LVEF >50%, n = 24) and noncompaction with reduced EF (LVEF <35%, n = 26) groups. Troponin I, troponin T, anti-troponin I IgM and anti-troponin T IgM were measured with sandwich immunoassay method using a commercially available kit. Patients with noncompaction had significantly higher troponin I (28.98±9.21 ng/ml in NCNE group and 28.11±10.42 ng/ml in NCLE group), troponin T (22.17±6.97 pg/ml in NCNE group and 22.78±7.76 pg/ml in NCLE group) and antitroponin I IgM (1.92±0.43 µg/ml in NCNE group and 1.79±0.36 µg/ml in NCLE group) levels compared to control group, while antitroponin T IgM and IgG were only elevated in patients with noncompaction and reduced EF (15.81±6.52 µg/ml for IgM and 16.46±6.25 µg/ml for IgG). Elevated cardiac troponins and anti-troponin I autoantibodies were observed in patients with noncompaction preceding the decline in systolic function and could indicate ongoing myocardial damage in these patients. Public Library of Science 2013-02-28 /pmc/articles/PMC3585198/ /pubmed/23469039 http://dx.doi.org/10.1371/journal.pone.0057648 Text en © 2013 Erer et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article Erer, Hatice Betül Güvenç, Tolga Sinan Kemik, Ahu Sarbay Yılmaz, Hale Yaka Kul, Şeref Altay, Servet Sayar, Nurten Kaya, Yüksel Eren, Mehmet Troponin and Anti-Troponin Autoantibody Levels in Patients with Ventricular Noncompaction |
title | Troponin and Anti-Troponin Autoantibody Levels in Patients with Ventricular Noncompaction |
title_full | Troponin and Anti-Troponin Autoantibody Levels in Patients with Ventricular Noncompaction |
title_fullStr | Troponin and Anti-Troponin Autoantibody Levels in Patients with Ventricular Noncompaction |
title_full_unstemmed | Troponin and Anti-Troponin Autoantibody Levels in Patients with Ventricular Noncompaction |
title_short | Troponin and Anti-Troponin Autoantibody Levels in Patients with Ventricular Noncompaction |
title_sort | troponin and anti-troponin autoantibody levels in patients with ventricular noncompaction |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3585198/ https://www.ncbi.nlm.nih.gov/pubmed/23469039 http://dx.doi.org/10.1371/journal.pone.0057648 |
work_keys_str_mv | AT ererhaticebetul troponinandantitroponinautoantibodylevelsinpatientswithventricularnoncompaction AT guvenctolgasinan troponinandantitroponinautoantibodylevelsinpatientswithventricularnoncompaction AT kemikahusarbay troponinandantitroponinautoantibodylevelsinpatientswithventricularnoncompaction AT yılmazhaleyaka troponinandantitroponinautoantibodylevelsinpatientswithventricularnoncompaction AT kulseref troponinandantitroponinautoantibodylevelsinpatientswithventricularnoncompaction AT altayservet troponinandantitroponinautoantibodylevelsinpatientswithventricularnoncompaction AT sayarnurten troponinandantitroponinautoantibodylevelsinpatientswithventricularnoncompaction AT kayayuksel troponinandantitroponinautoantibodylevelsinpatientswithventricularnoncompaction AT erenmehmet troponinandantitroponinautoantibodylevelsinpatientswithventricularnoncompaction |